These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 19540285)
1. Two clusters of mutations map distinct receptor-binding sites of echovirus 11 for the decay-accelerating factor (CD55) and for canyon-binding receptors. Rezaikin AV; Novoselov AV; Sergeev AG; Fadeyev FA; Lebedev SV Virus Res; 2009 Oct; 145(1):74-9. PubMed ID: 19540285 [TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution controls DAF-dependent phenotype of echovirus 11 in rhabdomyosarcoma cells. Novoselov AV; Rezaykin AV; Sergeev AG; Fadeyev FA; Grigoryeva JV; Sokolova ZI Virus Res; 2012 Jun; 166(1-2):87-96. PubMed ID: 22445689 [TBL] [Abstract][Full Text] [Related]
3. Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21. Johansson ES; Xing L; Cheng RH; Shafren DR J Virol; 2004 Nov; 78(22):12603-12. PubMed ID: 15507647 [TBL] [Abstract][Full Text] [Related]
4. Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells. Polacek C; Ekström JO; Lundgren A; Lindberg AM Virus Res; 2005 Nov; 113(2):107-15. PubMed ID: 15964091 [TBL] [Abstract][Full Text] [Related]
5. Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection. Stuart AD; McKee TA; Williams PA; Harley C; Shen S; Stuart DI; Brown TD; Lea SM J Virol; 2002 Aug; 76(15):7694-704. PubMed ID: 12097583 [TBL] [Abstract][Full Text] [Related]
6. Role of class I human leukocyte antigen molecules in early steps of echovirus infection of rhabdomyosarcoma cells. Chevaliez S; Balanant J; Maillard P; Lone YC; Lemonnier FA; Delpeyroux F Virology; 2008 Nov; 381(2):203-14. PubMed ID: 18823925 [TBL] [Abstract][Full Text] [Related]
7. Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF. Spiller OB; Goodfellow IG; Evans DJ; Almond JW; Morgan BP J Infect Dis; 2000 Jan; 181(1):340-3. PubMed ID: 10608785 [TBL] [Abstract][Full Text] [Related]
8. Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity. Shafren DR; Dorahy DJ; Thorne RF; Kinoshita T; Barry RD; Burns GF J Immunol; 1998 Mar; 160(5):2318-23. PubMed ID: 9498772 [TBL] [Abstract][Full Text] [Related]
9. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor. Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501 [TBL] [Abstract][Full Text] [Related]
10. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1. Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789 [TBL] [Abstract][Full Text] [Related]
11. Echovirus 6 strains derived from a clinical isolate show differences in haemagglutination ability and cell entry pathway. Lévêque N; Norder H; Zreik Y; Cartet G; Falcon D; Rivat N; Chomel JJ; Hong SS; Lina B Virus Res; 2007 Dec; 130(1-2):1-9. PubMed ID: 17566587 [TBL] [Abstract][Full Text] [Related]
12. Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor. Powell RM; Schmitt V; Ward T; Goodfellow I; Evans DJ; Almond JW J Gen Virol; 1998 Jul; 79 ( Pt 7)():1707-13. PubMed ID: 9680134 [TBL] [Abstract][Full Text] [Related]
13. Studies of Echovirus 5 interactions with the cell surface: heparan sulfate mediates attachment to the host cell. Israelsson S; Gullberg M; Jonsson N; Roivainen M; Edman K; Lindberg AM Virus Res; 2010 Aug; 151(2):170-6. PubMed ID: 20466025 [TBL] [Abstract][Full Text] [Related]
14. Interaction of decay-accelerating factor with coxsackievirus B3. Hafenstein S; Bowman VD; Chipman PR; Bator Kelly CM; Lin F; Medof ME; Rossmann MG J Virol; 2007 Dec; 81(23):12927-35. PubMed ID: 17804498 [TBL] [Abstract][Full Text] [Related]
15. Decay-accelerating factor binding determines the entry route of echovirus 11 in polarized epithelial cells. Sobo K; Rubbia-Brandt L; Brown TD; Stuart AD; McKee TA J Virol; 2011 Dec; 85(23):12376-86. PubMed ID: 21917947 [TBL] [Abstract][Full Text] [Related]
16. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Huang SW; Wang YF; Yu CK; Su IJ; Wang JR Virology; 2012 Jan; 422(1):132-43. PubMed ID: 22078110 [TBL] [Abstract][Full Text] [Related]
17. Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment. Pan J; Zhang L; Organtini LJ; Hafenstein S; Bergelson JM J Virol; 2015 Jan; 89(2):1324-8. PubMed ID: 25392210 [TBL] [Abstract][Full Text] [Related]
18. Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection. Newcombe NG; Johansson ES; Au G; Lindberg AM; Barry RD; Shafren DR J Virol; 2004 Feb; 78(3):1431-9. PubMed ID: 14722298 [TBL] [Abstract][Full Text] [Related]
19. Enterovirus 70 receptor utilization is controlled by capsid residues that also regulate host range and cytopathogenicity. Kim MS; Racaniello VR J Virol; 2007 Aug; 81(16):8648-55. PubMed ID: 17537857 [TBL] [Abstract][Full Text] [Related]
20. [Mapping of point mutations leading to loss of virus ECH011 affinity for receptor DAF (CD55)]. Rezaĭkin AB; Novoselov AB; Fadeev FA; Sergeev AG; Lebedev SB Vopr Virusol; 2009; 54(1):41-4. PubMed ID: 19253731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]